Clarity for Sponsors Building the Next Generation of CNS Therapies
CNS clinical development continues to evolve across indications, mechanisms, and trial design approaches. For sponsor teams, staying aligned with industry direction is essential to building confident development strategy.
The 2026 CNS Clinical Research Trends Report was developed to provide grounded perspective on how development momentum, evolving trial design thinking, and emerging therapeutic approaches are influencing CNS program strategy in the year ahead.
For Those Navigating What’s Next in CNS
The 2026 CNS Trends Report brings together perspective on where CNS clinical research is moving and what those shifts may mean for sponsors planning next steps.
What’s Inside the Report
The report highlights several areas currently influencing how CNS programs are being designed and advanced, including:
- Development momentum across CNS indications
How investment patterns, pipeline activity, and regulatory movement are shaping competitive positioning.
- Evolving thinking around trial design and execution
Why sponsors are reassessing design assumptions, endpoint strategy, and eligibility frameworks to support interpretability and execution confidence.
- Emerging therapeutic mechanisms
How newer modalities, including neuroplastogens and GLP-1 receptor agonists, are introducing new strategic and operational considerations.
SUPPORTING CONFIDENT DECISIONS
The 2026 Trends Report brings together the forces shaping CNS development today to help sponsors evaluate opportunity, anticipate complexity, and move forward with greater clarity.
